PERCEPTIVE ADVISORS LLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1224962 NEW YORK, NY

Position in CTMX

as of Mar 31, 2026 · filed May 29, 2026 Compact

Position Value

$47,464,472

+$6,226,884 QoQ

Shares Held

10,098,824

+4.3% QoQ

Ownership

4.64%

of shares outstanding

% of Portfolio

0.94%

of 13F equity value

Holder Rank

of 178 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PERCEPTIVE ADVISORS LLC holds $4,570,707,559 across 67 Biotechnology names. CTMX ranks #23 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	2,035,986	$655,974,329
2	CELC	Celcuity Inc.	3,127,200	$356,938,608
3	ASND	Ascendis Pharma A/S	1,531,421	$350,281,925
4	ROIV	Roivant Sciences Ltd.	8,285,461	$229,507,269
5	CNTA	Centessa Pharmaceuticals plc	5,258,903	$208,883,627
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,373,795	$206,448,951
7	SYRE	Spyre Therapeutics, Inc.	3,783,225	$190,825,869
8	NUVL	Nuvalent, Inc.	1,580,505	$161,922,737

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$47,464,472	10,098,824	+4.3%	Shares	Sole	2026-05-29
2025-12-31	$41,237,588	9,680,185	0.0%	Shares	Sole	2026-02-17
2025-09-30	$30,879,790	9,680,185	0.0%	Shares	Sole	2025-11-14
2025-08-14	$17,037,125	9,680,185	+38.4%	Shares	Sole	2025-08-21
2025-06-30	$15,875,576	6,993,646	+326.2%	Shares	Sole	2025-08-14
2021-06-30	$10,387,257	1,640,957	-23.8%	Shares	Sole	2021-08-17
2021-03-31	$16,650,219	2,153,974	-16.4%	Shares	Sole	2021-08-13
2020-12-31	$16,879,631	2,577,043	0.0%	Shares	Sole	2021-02-16
2020-09-30	$17,137,335	2,577,043	0.0%	Shares	Sole	2020-11-16
2020-06-30	$21,466,768	2,577,043	-20.8%	Shares	Sole	2020-08-17
2020-03-31	$24,957,589	3,253,923	—	Shares	Sole	2020-05-18
No filing history on record for this holder in this stock.